Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Ramiven 100mg Tablet is an anti-cancer medication utilized in the treatment of metastatic breast cancer. Its primary function is to impede the growth of cancer cells and ultimately induce their demise, thereby addressing symptoms associated with breast cancer, such as breast lumps, bloody discharge from nipples, or alterations in breast shape.
Administration and Dosage:
Ramiven 100mg Tablet can be taken with or without food and is typically administered in combination with another medication. The duration of treatment is contingent upon individual requirements and response to therapy. It is imperative to adhere to the precise dosage and duration prescribed by your healthcare provider. Regular blood tests may be recommended during the course of treatment to monitor its effectiveness and evaluate any potential side effects.
Indications:
The principal indication for Ramiven 100mg Tablet is in the management of metastatic breast cancer.
Benefits:
Ramiven 100mg Tablet offers several benefits in the treatment of metastatic breast cancer. It may be utilized alone or in combination with other medications or therapeutic modalities such as chemotherapy. This medication is typically employed when other treatments have not resulted in significant improvement, and the cancer has metastasized to other regions. Ramiven 100mg Tablet effectively alleviates symptoms associated with breast cancer, including breast lumps, bloody discharge from nipples, or changes in breast shape or texture. Additionally, it halts or impedes the growth of cancer cells and inhibits their proliferation. Should any side effects arise, it is advisable to discuss them with your healthcare provider.
Mechanism of Action:
Ramiven 100mg Tablet operates by blocking the action of an abnormal protein responsible for stimulating the multiplication of cancer cells. This mechanism helps to slow down or prevent the spread of cancer cells within the body.